Medicare Enrolled
Dr. Michael Borkin, MD
Dermatology · Birmingham, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Borkin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borkin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Borkin
Dr. Michael Borkin is a dermatology specialist in Birmingham, MI, with 14 years of NPI registration. Based on federal Medicare data, Dr. Borkin performed 2,128 Medicare services across 975 unique beneficiaries.
Between the years covered by Open Payments, Dr. Borkin received a total of $7,216 from 43 pharmaceutical and/or device companies across 392 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Borkin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 36% volume in MI
$7,216 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,128
Medicare services
Top 36% in MI for dermatology
975
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~152 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
710 | $5 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
487 | $65 | $139 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
244 | $39 | $104 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
244 | $80 | $174 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
68 | $61 | $156 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
60 | $42 | $87 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
60 | $1 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $91 | $197 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
47 | $30 | $88 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
45 | $81 | $174 |
| Destruction of skin growth, 15 or more growths | 30 | $92 | $204 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
26 | $96 | $194 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
14 | $91 | $189 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
13 | $244 | $471 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
12 | $95 | $194 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
12 | $102 | $380 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,216
Total received (2018-2024)
Avg $1,031/year across 7 years
Top 24% in MI for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
392
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,824 (94.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$392 (5.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,084
2023
$1,528
2022
$1,077
2021
$956
2020
$661
2019
$1,207
2018
$705
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$187
Janssen Biotech, Inc.
$138
Regeneron Healthcare Solutions, Inc.
$132
E.R. Squibb & Sons, L.L.C.
$69
Lilly USA, LLC
$62
Organogenesis Inc.
$59
LEO Pharma Inc.
$58
UCB, Inc.
$53
Dermavant Sciences, Inc.
$43
Incyte Corporation
$40
Novartis Pharmaceuticals Corporation
$40
SUN PHARMACEUTICAL INDUSTRIES INC.
$37
GENZYME CORPORATION
$36
PFIZER INC.
$30
Ortho Dermatologics, a division of Bausch Health US, LLC
$24
REVANCE THERAPEUTICS, INC.
$23
Journey Medical Corporation
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Galderma Laboratories, L.P.
$14
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$709
GENZYME CORPORATION
$504
Ortho Dermatologics, a division of Bausch Health US, LLC
$497
Regeneron Healthcare Solutions, Inc.
$427
Galderma Laboratories, L.P.
$377
Novartis Pharmaceuticals Corporation
$350
PFIZER INC.
$332
ABBVIE INC.
$323
AbbVie, Inc.
$309
EPI Health, LLC
$309
AbbVie Inc.
$305
Dermavant Sciences, Inc.
$237
Almirall LLC
$224
Sun Pharmaceutical Industries Inc.
$216
Genentech USA, Inc.
$210
Lilly USA, LLC
$169
Mayne Pharma Inc.
$160
LEO Pharma Inc.
$158
UCB, Inc.
$155
E.R. Squibb & Sons, L.L.C.
$152
SUN PHARMACEUTICAL INDUSTRIES INC.
$145
Incyte Corporation
$122
Encore Dermatology Inc.
$107
VYNE Pharmaceuticals Inc.
$89
Sandoz Inc.
$71
MAYNE PHARMA INC.
$59
Organogenesis Inc.
$59
Arcutis Biotherapeutics, Inc.
$54
Amgen Inc.
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Promius Pharma LLC
$39
Merck Sharp & Dohme Corporation
$35
DERMIRA, INC.
$35
MAYNE PHARMA COMMERCIAL LLC
$25
Melinta Therapeutics, Inc.
$24
REVANCE THERAPEUTICS, INC.
$23
Aclaris Therapeutics, Inc.
$23
Journey Medical Corporation
$21
Verrica Pharmaceuticals Inc.
$19
DUSA Pharmaceuticals, Inc.
$17
Biofrontera Inc.
$16
Paratek Pharmaceuticals, Inc.
$13
Sebela Pharmaceuticals Inc.
$12
Top 3 companies account for 23.7% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AFFINITY · AKLIEF · ALTRENO · AMZEEQ · ARAZLO · Absorica LD · Aczone · Ameluz · BIAFINE · BOTOX · BRYHALI · Baxdela · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Cloderm Cream · Cordran · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EFUDEX · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · JUBLIA · KERYDIN · LEVULAN KERASTICK · LIBTAYO · NAFTIN · NUZYRA · ONEXTON · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · WYNZORA · Winlevi · YCANTH · ZILXI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
224
Per 100K population
17.6
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL ROYAL OAK
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Borkin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Borkin experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Borkin performed 710 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Borkin receive payments from pharmaceutical companies?
Yes. Dr. Borkin received a total of $7,216 from 43 companies across 392 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borkin's costs compare to other dermatologists in Birmingham?
Dr. Borkin's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borkin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Birmingham
Browse dermatologists in Birmingham ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in MI
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in MI
Which MI dermatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Ortho Dermatologics, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Ortho Dermatologics, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology